Diagnostic value of pleural fluid N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases

Respirology

Volumn 13, Issue 1, 2008, Pages 53-57

  Liao, Huai ^a,b,c   Na, Moon Jun ^b,c   Dikensoy, Oner ^b,c   Lane, Kirk B ^c   Randal, Barnette ^b,c   Light, Richard W ^b,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Brain natriuretic peptide; Diagnosis; Pleural effusion

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARCINOMA; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG EMBOLISM; MALE; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; CARCINOMA; CORONARY ARTERY BYPASS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PLEURAL EFFUSION; PLEURAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PULMONARY EMBOLISM;

EID: 38049177387     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2007.01191.x     Document Type: Article

References (20)

1. Light RW. Pleural Diseases, 4th edn. Lippincott Williams & Wilkins, Philadelphia, PA, 2001.
2. Light RW. Pleural effusion. N. Engl. J. Med. 2002 346 : 1971 7.
3. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988 332 : 78 81.
4. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM et al. American College of Cardiology/American Heart Association. ACC/AHA guidelines for the evaluation and management of chronic CHF in the adult: executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of CHF). J. Am. Coll. Cardiol. 2001 38 : 2101 13.
5. Remme WJ, Swedberg K. Task Force for the Diagnosis and Treatment of Chronic CHF, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic CHF. Eur. Heart J. 2001 22 : 1527 60.
6. Pfister R, Schneider CA. Natriuretic peptides BNP and NT-pro-BNP: established laboratory markers in clinical practice or just perspectives? Clin. Chim. Acta 2004 349 : 25 38.
7. Januzzi JL, Camargo CA, Anwaruddin S, Baggish AL, Chen AA et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am. J. Cardiol. 2005 95 : 948 54.
8. Tomcsanyi J, Nagy E, Somloi M, Moldvay J, Bezzegh A et al. NT-brain natriuretic peptide levels in pleural fluid distinguish between pleural transudates and exudates. Eur. J. Heart Fail. 2004 6 : 753 6.
9. Porcel JM, Vives M, Cao G, Esquerda A, Rubio M et al. Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to CHF. Am. J. Med. 2004 116 : 417 20.
10. Torbicki A, van Beek EJR, Charbonnier B. Guidelines on diagnosis and management of acute pulmonary embolism. Eur. Heart J. 2000 21 : 1301 36.
11. Vasan RS, Benjamin EJ, Larson MG, Leip EP, Wang TJ et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction. JAMA 2002 288 : 1252 9.
12. Pruszczyk P, Kostrubiec M, Bochowicz A, Styczynski G, Szulc M et al. N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. Eur. Respir. J. 2003 22 : 649 53.
13. Tulevski II, Hirsch A, Sanson BJ, Romkes H, van der Wall EE et al. Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism. Thromb. Haemost. 2001 86 : 1193 6.
14. Kruger S, Graf J, Merx MW, Koch KC, Kunz D et al. Brain natriuretic peptide predicts right CHF in patients with acute pulmonary embolism. Am. Heart J. 2004 147 : 60 5.
15. Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003 107 : 2545 7.
16. Leuchte HH, Holzapfel M, Baumgartner RA, Ding I, Neurohr C et al. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. J. Am. Coll. Cardiol. 2004 43 : 764 70.
17. Yap LB, Ashranfian H, Mukerjee D, Coghlan JG, Timms PM. The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension. Clin. Biochem. 2004 37 : 847 56.
18. Gegenhuber A, Mueller T, Dieplinger B, Lenz K, Poelz W et al. Plasma B-type natriuretic peptide in patients with pleural effusions: preliminary observations. Chest 2005 128 : 1003 9.
19. Palazzuoli A, Carrera A, Calabria P, Pastore M, Quatrini I et al. Brain natriuretic peptide levels during cardiac reperfusion: comparison between percutaneous coronary angioplasty and aorto-coronaric bypass. Clin. Chim. Acta 2004 342 : 87 92.
20. Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann. Intern. Med. 1972 77 : 507 13.